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A b stract. This paper describes a novel m ethod for improving classifi­
cation of support vector machines (SVM) with recursive feature selection 
(SVM-RFE) when applied to  cancer classification with gene expression 
da ta . The m ethod employs pairs of support vectors of a linear SVM- 
RFE classifier for generating a sequence of new SVM classifiers, called 
local support classifiers. This sequence is used in two Bayesian learning 
techniques: as ensemble of classifiers in O ptim al Bayes, and as a ttribu tes 
in Naive Bayes. The resulting classifiers are applied to  four publically 
available gene expression datasets from leukemia, ovarian, lymphoma, 
and colon cancer da ta , respectively. The results indicate th a t the pro­
posed approach improves significantly the predictive performance of the 
baseline SVM classifier, its stability  and robustness, w ith satisfactory re­
sults on all datasets. In particular, perfect classification is achieved on 
the leukemia and ovarian cancer datasets.
1 In trod u ction
This paper deals with tum or classification with gene expression data. Microarray 
technology provides a tool for estimating expression of thousands of genes simul­
taneously. To this end, DNA arrays are used, consisting of a large number of DNA 
molecules spotted in a systematic order on a solid substrate. Depending on the 
size of each DNA spot on the array, DNA arrays are called microarrays when the 
diameter of DNA spot is less than 250 microns, and macroarrays when the diame­
ter is bigger than  300 microns. DNA microarrays contain thousands of individual 
DNA sequences printed in a high density array on a glass microscope slide using 
a robotic instrument. The relative abundance of these spotted DNA sequences in 
the two DNA and RNA samples may be assessed by monitoring the differential 
hybridization of the two samples to  the sequences on the array. For mRNA sam­
ples, the two samples are reverse-transcribed into cDNA, labeled using different 
fluorescent dyes mixed (red-fluorescent dye Cy5 and green-fluorescent dye Cy3). 
After these samples are hybridized with the arrayed DNA probes, the slides are
imaged using scanner th a t makes fluorescence measurements for each dye. The 
log ratio between the two intensities of each dye is used as the gene expression 
data (cf. [11]) expression(gene)  =  log2(int(Cy5)/int(Cy3)),  were int(Cy5)  and 
int(Cy3) are the intensities of the two fluorescent dyes.
Four main machine learning tasks are used to  analyze DNA microarray data: 
clustering, e.g. for identifying tum or subtypes, classification, e.g. for tum or diag­
nostic, feature selection for potential tum or biomarker identification, and gene 
regulatory network modeling. This paper deals with classification.
Many machine learning techniques have been applied to  classify gene ex­
pression data, including Fisher linear discriminat analysis [10], k-nearest neigh­
bour [18], decision tree, multi-layer perceptron [17,25], support vector machine 
(SVM) [6,13,15,21], boosting and ensemble methods [14,7,23,3,9]. A recent 
comparison of classification and feature selection algorithms applied to  tum or 
classification can be found in [7,23].
This paper introduces a method th a t improves the predictive performance of 
a linear SVM with Recursive Feature Elimination (SVM-RFE) [15] on four gene 
expression datasets. The method is motivated by previous work on aggregration 
of classifiers [4, 5], where it is shown th a t gains in accuracy can be obtained by 
aggregrating classifiers built from perturbed versions of the train  set, for instance 
using bootstrapping. Application of aggregration of classifiers to  microarray data 
is described e.g. in [10,7,3,9].
In this paper a novel approach is proposed, for generating a sequence of 
classifiers from the support vectors of a baseline linear SVM-RFE classifier. 
Each pair of support vectors of the same class are used to  generate an element 
of the sequence, called local support classifier (Isc). Such classifier is obtained by 
training SVM-RFE on data consisting of the two selected support vectors and 
all the support vectors of the other class.
The sequence of Isc’s provides an approximate description of the data distri­
bution by means of a set of linear decision functions, one for each region of the 
input space in a small neighbourhoods of two support vectors having equal class 
label.
We propose to  use this sequence of classifiers in Bayesian learning (cf. [20]). 
The first technique applies Naive Bayes to  the transformed data, where an ex­
ample is mapped into the binary vector of its classification values. The resulting 
classifier is called Naive Bayes Local Support Classifier (NB-LSC). The second 
technique applies Optimal Bayes to the sequence of Isc’s classifiers. The resulting 
classifier is called Optimal Bayes Local Support Classifier (OB-LSC).
The two classifiers are applied to  four publically available datasets for cancer 
classification with gene expression. The results show a significant improvement 
in predictive performance of OB-LSC over the baseline linear SVM-RFE classi­
fier, and a gain in stability. In particular, on the leukemia and ovarian cancer 
datasets perfect classification is obtained, and on the other datasets performance 
comparable to  the best published results we are aware of.
The rest of the paper is organized as follows. The next two sections describe 
the baseline and new methods. Sections 4 contains a short description of the
data. Section 5 reports results of experiments and discuss them. Finally, the 
paper ends with conclusive considerations on research issues to  be tackled in 
future work.
2 Support V ector M achines
This section describes in brief SVM-RFE, the local support classifier construction 
procedure, and the integration of the resulting classifier sequence in Naive Bayes 
and Optimal Bayes classification.
2.1 SV M
In linear SVM binary classification [24,8] patterns of two classes are linearly 
separated by means of a maximum margin hyperplane, th a t is, the hyperplane 
tha t maximizes the sum of the distances between the hyperplane and its closest 
points of each of the two classes (the margin). When the classes are not linearly 
separable, a variant of SVM, called soft-margin SVM, is used. This SVM vari­
ant penalizes misclassification errors and employs a param eter (the soft-margin 
constant C) to  control the cost of misclassification.
Training a linear SVM classifier amounts to  solving the following constrained 
optimization problem:
with one constraint for each training example x j . Usually the dual form of 
the optimization problem is solved:
such th a t 0 < a j < C, ^ ™ i a iVi =  0. SVM requires O (m 2) storage and O(m 3) 
to  solve.
The resulting decision function f  (x) =  w ■ x  +  b has weight vector w =  
1 a kVkx k. Examples Xj for which a j > 0 are called support vectors, since 
they define uniquely the maximum margin hyperplane.
Maximizing the margin allows one to  minimize bounds on generalization 
error. Because the size of the margin does not depend on the data dimension, 
SVM are robust with respect to  data with high input dimension. However, SVM 
are sensitive to  the presence of (potential) outliers, (cf. [15] for an illustrative 
example) due to  the regularization term  for penalizing misclassification (which 
depends on the choice of C).
w ■ Xj +  b > 1 -  &
j = 1
j= 1 j = 1 j=1
2.2 SVM -RFE
The weights w j provide information about feature relevance, where bigger weight 
size implies higher feature relevance. In this paper feature x j is scored by means 
of the absolute value of w j. Other scoring functions based on weight features are 
possible, like, e.g., w2, which is used in the original SVM-RFE algorithm [15].
SVM-RFE is an iterative algorithm. Each iteration consists of the following 
two steps. First feature weights, obtained by training a linear SVM on the train ­
ing set, are used in a scoring function for ranking features as described above. 
Next, the feature with minimum rank is removed from the data. In this way, a 
chain of feature subsets of decreasing size is obtained.
In the original SVM-RFE algorithm one feature is discarded at each iteration. 
Other choices are suggested in [15], where at each iteration features with rank 
lower than  a user-given theshold are removed. In general, the threshold influences 
the results of SVM-RFE [15]. In this paper we use a simple instance of SVM- 
RFE where the user specifies the number of features to  be selected, 70% of the 
actual number of features are initially removed, and then 50% at each further 
iteration. These values are chosen after cross-validation applied to  the training 
set.
3 Local Support Classifiers
We propose to  describe the distribution of the two classes by means of a sequence 
of classifiers, generated from pairs of support vectors ofSVM-RFE. Each of these 
classifiers, called local support classifier (Isc), is obtained using data generated 
from two support vectors of the same class, and all support vectors of the other 
class. In this way, each classifier uses only a local region near the two selected 
support vectors when separating the two classes. Each classifier generated from 
two (distinct) support vectors of the same class provides an approximate de­
scription of the distribution of the other class given the two selected support 
vectors.
Before describing the procedure for constructing Isc’s, some notation used 
throughout the paper is introduced.
— D  denotes the training set,
— c denotes the classifier obtained by training a linear SVM on D,
— Sp and S n denote the set of positive and negative support vectors of c, 
respectively,
— Pairp and Pairn denote the set of pairs of distinct elements of Sp and Sn , 
respectively.
The following procedure, called LSC, takes as input one (s, s') in Pairp and 
outputs a linear SVM classifier Cs s/ by means of the following two steps.
1. Let X p  =  {s, s'}. Assign positive class label to  these examples.
2. Let Cs s/ be the classifier obtained by training a linear SVM on data X pUSn.
An analogous procedure is applied to  generate Cs,s/ from pairs (s, s') in 
Pairn.
When applied to  all pairs of support vectors in Pairp, Pai rn , LSC produces 
a sequence of Isc’s. Such sequence of classifiers induces a data transformation, 
called seqD, which maps example x  in the sequence seqD (x) of class values 
Cs,s/ (x), with (s, s') in Pairp U Pairn .
The construction of the sequence of Isc’s requires computation th a t grows 
quadratically with the number of support vectors. However, this is not a severe 
problem, since the number of examples, hence of support vectors, is small for 
this type of data. Furthermore, LSC is applied to  each pair of support vectors 
independently, hence can be executed in parallel.
3.1 N aive B ayes a n d  O p tim a l B ayes C lassifica tio n
Naive Bayes (NB) is based on the principle of assigning to  a new example the 
most probable target value, given the attribute values of the example. In order 
to  apply directly NB to the original gene expression data, gene values need to  be 
discretized, since NB assumes discrete-valued attributes. Examples transformed 
using seqD contain binary attributes, hence discretization is not necessary.
Let x  be a new example. Suppose seqD(x) =  (x1, . . .  , x N).
First, the prior probabilities py of the two target values are estimated by 
means of the frequency of positive and negative examples occurring in the train  
set D, respectively. Next, for each attribute value x j , the probability P ( x j | y) 
of xj given target value V is estimated as the frequency with which xj  occurs as 
value of i-th attribute among the examples of D  with class value y . Finally, the 
classification of x  is computed as the y th a t maximizes the product
The resulting classifier is denoted by NB-LSC.
Optimal Bayes (OB) classifier is based on the principle of maximizing the 
probability th a t a new example is classified correctly, given the available data, 
classifiers, and prior probabilities over the classifiers.
OB maps example x  to  the class tha t maximizes the weighted sum
where wsy  is the accuracy of Csy  over D, and I  is the indicator function, which 
returns 1 if the test contained in its argument is satisfied and 0 otherwise. The 
resulting classifier is denoted by OB-LSC.
4 D a tasets
N
P y \ \  P  (xi 1 y ) -
i=l
There are several microarray datasets from published cancer gene expression 
studies, including leukemia cancer dataset, colon cancer dataset, lymphoma
dataset, breast cancer dataset, NCI60 dataset, ovarian cancer, and prostate 
dataset. Among them four datasets are used in this paper, available e.g. at 
h t t p : / / s d m c . l i t . o rg .sg /G E D atase ts /D a tase ts .h tm l. The first and third dataset 
contain samples from two variants of the same disease, the second and last 
dataset consist of tum or and normal samples of the same tissue. Table 1 shows 
input dimension and class sizes of the datasets. The following short description 
of the datasets is partly based on [7].
T able 1. Datasets description
Name Tot Positive Negative Genes
Colon 62 22 40 2000
Leukemia 72 25 47 7129
Lymphoma 58 26 32 7129
Ovarian 54 30 24 1536
4.1 L eu k em ia
The Leukemia dataset consists of 72 samples: 25 samples of acute myeloid 
leukemia (AML) and 47 samples of acute lymphoblastic leukemia (ALL). The 
source of the gene expression measurements is taken from 63 bone marrow sam­
ples and 9 peripheral blood samples. Gene expression levels in these 72 samples 
are measured using high density oligonucleotide microarrays [2]. Each sample 
contains 7129 gene expression levels.
4.2 C o lon
The Colon dataset consists of 62 samples of colon epithelial cells taken from 
colon-cancer patients. Each sample contains 2000 gene expression levels. Al­
though the original data consists of 6000 gene expression levels, 4000 out of 
6000 were removed based on the confidence in the measured expression levels. 
40 of 62 samples are colon cancer samples and the remaining are normal samples. 
Each sample is taken from tumors and normal healthy parts of the colons of the 
same patients and measured using high density oligonucleotide arrays [1].
4.3 L y m p h o m a
B cell diffuse large cell lymphoma (B-DLCL) is a heterogeneous group of tumors, 
based on significant variations in morphology, clinical presentation, and response 
to treatm ent. Gene expression profiling has revealed two distinct tum or subtypes 
of B-DLCL: germinal center B cell-like DLCL and activated B cell-like DLCL 
[19]. Lymphoma dataset consists of 24 samples of germinal center B-like and 23 
samples of activated B-like.
4.4 Ovarian
Ovarian tissue from 30 patients with cancer and 23 without cancer were analyzed 
for mRNA expression using glass arrays spotted for 1536 gene clones. Attribute
i of patient j  is the measure of the mRNA expression of the i-th  gene in tha t 
tissue sample, relative to  control tissue, with a common control employed for all 
experiments [22].
5 N um erical E xperim en ts
The two classifiers NB-LSC and OB-LSC, described in Section 3.1, are applied 
to the four gene expression datasets the baseline SVM-RFE algorithm. In all 
experiments the same value of the SVM param eter C  =  10 is used, while the 
number of selected genes was set to  30 for the lymphoma dataset and 50 for all 
other datasets. These values are chosen by means of cross-validation applied to 
the training set.
Because of the small size of the datasets, Leave One Out Cross Validation 
(LOOCV) is used to  estimate the predictive performance of the algorithms [12].
T able 2. Results of LOOCV: average sensitivity, specificity and accuracy (with stan­
dard deviation between brackets).
M ethod D ataset Sensitivity Specificity Accuracy
SVM -RFE Colon
NB-LSC
OB-LSC
0.90 (0.3038) 
0.75 (0.4385) 
0.90 (0.3038)
1.00 (0.00)
1.00 (0.00)
1.00 (0.00)
0.9355 (0.2477) 
0.8387 (0.3708) 
0.9355 (0.2477)
SVM -RFE Leukemia
NB-LSC
OB-LSC
0.96 (0.20) 
1.00 (0.00) 
1.00 (0.00)
1.00 (0.00) 
1.00 (0.00) 
1.00 (0.00)
0.9861 (0.1179) 
1.00 (0.00)
1.00 (0.00)
SVM -RFE Ovarian
NB-LSC
OB-LSC
0.7000 (0.4661) 0.9583 (0.2041) 0.8148 (0.3921) 
1.00 (0.00) 1.00 (0.00) 1.00 (0.00)
1.00 (0.00) 1.00 (0.00) 1.00 (0.00)
SVM -RFE Lymphoma
NB-LSC
OB-LSC
0.6923 (0.4707) 0.6562 (0.4826) 0.6724 ( 0.4734)
1.00 (0.00) 0.6562 (0.4826) 0.8103 (0.3955)
1.00 (0.00) 0.8750 (0.3360) 0.9310 (0.2556)
Table 2 reports results of LOOCV. They indicate a statistically significant 
improvement of OB-LSC over the baseline SVM-RFE classifier, and a gain in sta­
bility, indicated by lower standard deviation values. In particular, on the ovarian 
and leukemia datasets both NB-LSC and OB-LSC achieve perfect classification.
Moreover, while the performance of SVM on the Lymphoma dataset is rather 
scare (possibly due to  the fact th a t we did not scale the data), OB-LSC obtains 
results competitive to  the best results known (see Table 3).
T able 3. Comparison of results with best average accuracy reported in previous papers 
on tum or classification. The type of classifiers considered in the paper are given between 
brackets. An entry ’- ’ means th a t the corresponding dataset has not been considered.
Colon Leukemia Lymphoma Ovarian
Furey et al (SVM) 0.90 0.94 - -
Li et al 00 (Logistic regression) - 0. 94 - -
Li et al 01 (KNN) 0.94 - 0.94 -
Ben-Dor et al (Q uadratic SVM, INN, AdaBoost) 0.81 0.96 - -
Dudoit et al (INN, LDA, BoostCART) - 0.95 0.95 -
Nguyen et al (Logistic discriminant, QDA) 0.94 0.96 0.98 -
Cho et al ( Ensemble SVM, KNN) 0.94 0.97 0.96 -
Liu et al 04 (Ensemble NN) 0.91 - - -
Dettling et al 03 (Boosting) 0.85 - - -
OB-LSC 0.94 1.00 0.93 1.00
Table 3 reports results of OB-LSC and the best result among those contained 
nine papers on tum or classification and feature selection using different machine 
learning methods [7]. Note th a t results reported in this table have been obtained 
using different cross-validation methods, mainly by repeated random partitioning 
the data into train  and test set using 70 and 30 % of the data, respectively. 
Because the resulting estimate of predictive performance may be more biased 
than the one of LOOCV [12], those results give only an indication for comparing 
the methods. Only the results on the colon dataset from Liu et al 04 and Dettling 
et al 03 [9,3] are obtained using LOOCV. The methods proposed in these latter 
papers use boosting and bagging, respectively. The results they obtain seem 
comparable to  OB-LSC.
The results indicate th a t OB-LSC is competitive with most recent classifica­
tion techniques for this task, including non-linear methods.
6 C onclusion
This paper introduced an approach tha t improves predictive performance and 
stability of linear SVM for tum or classification with gene expression data on four 
gene expression datasets.
We conclude with two considerations on research issues still to  be addressed. 
Our approach is at this stage still an heuristic, and needs further experimental 
and theoretical analysis. In particular, we intend to  analyze how performance is 
related to  the number of support vectors chosen to  generate Isc’s. Moreover, we 
intend to  investigate the use of this approach for feature selection, for instance 
whether the generated Isc’s can be used for ensemble feature ranking [16].
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